USE OF CALCIUM SALT FORMULATION FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING

• 1. 改变粘膜内衬生物物理特性的配方 [P] . 中国专利： CN102327285A . 2012-01-25
• 2. 改变粘膜内衬生物物理特性的配方 [P] . 中国专利： CN101237853A . 2008-08-06
• 3. CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING [P] . IN2011DN07376A . 2012-12-28

  机译： 柠檬酸钙和乳酸钙配方改变粘膜衬里生物物理特性

• 4. CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING. [P] . MX2011009956A . 2012-01-27

  机译： 柠檬酸钙和乳酸钙配方可改变粘膜衬里的生物物理特性。

• 5. CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING [P] . 欧洲知识产权局专利： EP2410986A2 . 2012-02-01

  机译： 柠檬酸钙和乳酸钙配方改变粘膜衬里生物物理特性

• 1. Insulating Permanent Lining of Calcium Hexaluminate Based Castable for 300t Ladle in Baosteel [J] . GAN Feifang, GUO Zongqi, GAO Jianying, 中国耐火材料（英文版） . 2021,第001期
• 2. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation. [J] . Schwille PO, Schmiedl A, Wipplinger J European journal of medical research. . 2009,第9期
• 3. Effect of Di(2-ethyl hexyl phthalate)/Epoxidized Soybean Oil and Calcium Stearate/Zinc Stearate Ratios on the Tensile Properties of Plasticized PVC Formulations. A Study for Calcium Stearate Rich Formulations [J] . Gonzalez-Ortiz LJ, Arellano M, Sanchez-Pena MJ Macromolecular symposia . 2009,第Null期
• 4. Determination of Sensory Thresholds of Selected Calcium Salts and Formulation of Calcium-fortified Pocket-type Flat Bread [J] . GHADA ZIADEH, SOSSY SHADAREVIAN, AMAL MALEK, Journal of Food Science . 2005,第8期
• 5. Effect of Di(2-ethyl hexyl phthalate)/Epoxidized Soybean Oil and Calcium Stearate/Zinc Stearate Ratios on the Tensile Properties of Plasticized PVC Formulations. A Study for Calcium Stearate Rich Formulations [C] . Luis J. Gonzalez-Ortiz, Martin Arellano, M. Judith Sanchez-Pena US-Mexico Symposium on Advances in Polymer Science . 2009
• 6. Sphingosine-induced Alterations in Membrane Biophysical Properties: Biological Relevance in the Pathophysiology of Human Disease [D] . Carreira, Ana Cláudia Nunes. 2019
• 7. Idiopathic Recurrent Calcium Urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition calcium salt crystallization and stone formation* [O] . PO Schwille, A Schmiedl, J Wipplinger 2009
• 8. Idiopathic Recurrent Calcium Urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation* [O] . Schwille, PO, Schmiedl, A, Wipplinger, J 2009

• 1. Bioavailability and Solubility of Different Calcium-Salts as a Basis for Calcium Enrichment of Beverages [J] . Gaby Kressel . 食品与营养科学（英文） . 2010,第2期
• 2. Reversing gastric mucosal alterations during ethanol-induced chronic gastritis in rats by oral administration of Opuntia ficus-indica mucilage [J] . Ricardo Vázquez-Ramírez ,Marisela Olguín-Martínez ,Carlos Kubli-Garfias . 世界胃肠病学杂志：英文版 . 2006,第27期
• 3. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection,histological types and staging [J] . Heng Jun Gao ,Lian Zhen Yu ,Jian Feng Bai . 世界胃肠病学杂志：英文版 . 2000,第6期
• 4. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis [J] . Renata D’Incà ,Martina Paccagnella ,Romilda Cardin . 世界胃肠病学杂志：英文版 . 2013,第34期
• 5. 新型生物制剂在克罗恩病治疗中应用的现状和展望：将改变克罗恩病的自然病程作为下一步的研究目标? [C] . . 中华医学会第八次全国消化疾病学术会议 . 2008
• 6. 生物钟基因Per1、Per2与细胞周期相关基因在口腔颊粘膜癌变不同阶段昼夜节律表达改变的动态研究 [A] . 谭雪梅 . 2015